According to Genetic Signatures latest financial reports the cash on hand of GSS is $11.06M, an decrease of -55.69% to 2022. At the end of 2022 company had $24.96M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $11.06M | -55.69% |
2022 | $24.96M | 22.50% |
2021 | $20.38M | -3.38% |
2020 | $21.09M | 393.95% |
2019 | $4.27M | - |